Bharat Parenterals Ltd. Stock Analysis 541096.BO

Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Vadodara, Gujarat and currently employs 393 full-time employees. The company went IPO on 2018-03-21. The firm is engaged in manufacturing of pharmaceutical formulations. The firm offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies. The company has a manufacturing facility spread over 30,000 square feet (sq. ft.) area with a large batch-sized capacity for general: tablets, capsules, oral liquids, eye drops, ointments, lotions, creams, and others.